While drugs like rapamycin and senolytics can slow certain ageing processes, truly stopping or reversing human ageing remains elusive. Emerging reprogramming techniques show promise, but safety and regulatory hurdles still leave healthy habits as today’s best anti-ageing strategy.

Whether AI agents become tools, teammates, or threats depends on how they are deployed. With reskilling and ethical safeguards, they amplify human potential rather than replace it.

The agent economy, powered by tools like OpenAI’s Operator, lets AI handle travel bookings, shopping, and payments, promising a trillion-dollar market by 2028 but sparking security and regulatory concerns.

AI drones are reshaping delivery, monitoring, and rescue operations with real-time intelligence and autonomy, but their safe integration into airspace hinges on evolving regulations, strong privacy safeguards, and robust security measures.

Agentic AI enables LLMs to plan, use tools, and act autonomously, evolving from chatbots into doers. Key enablers include reasoning, tool calling, and memory, but it also brings safety and hallucination challenges.

CRISPR 2.0 tools such as base and prime editing rewrite DNA with precision, avoiding breaks. They’ve led to approved therapies like Casgevy for sickle cell disease, yet ethical and access challenges remain.

The EU, US, and China are racing to regulate AI, but legislation struggles to keep up with rapid advances. Striking a balance between safety and innovation while avoiding regulatory capture remains the key challenge.

Wearables convert the body into a continuous data source that enables early diagnosis and tailored health recommendations, yet they raise urgent privacy issues: sensitive physiological data is often left unprotected and monetized.